Context Therapeutics CNTX
NASDAQ CNTX
$0.17 +0.00 (+0.00%)
At close: Nov 19, 2026 · 4:00 PM EST

Context Therapeutics (CNTX) Long-Term Investments (2022 - 2026)

Updated

Context Therapeutics' Long-Term Investments was $201,360 in Q3 2026.

Analysis

Context Therapeutics (CNTX) Long-Term Investments (2022 - 2026) Analysis & Trends

At the end of FY2025, Long-Term Investments at Context Therapeutics came in at $110,410, down 49.5% from FY2024.

  • Long-Term Investments shows a three-year compound annual growth rate of 28.6% (FY2022 to FY2025).
  • In earlier years, Long-Term Investments was $218,816 in FY2024 and $51,967 in FY2022.
  • The Q3 2026 figure marks the highest quarterly Long-Term Investments since Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 150.00 Bn
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn 4.01 Bn
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn -
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn 387.00 Mn
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 1.60 Bn
6 Novartis Ag 291.91 Bn 265.14 Bn - 63.00 Mn
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn -
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn -
9 Gsk 193.54 Bn 176.38 Bn - 64.84 Mn
10 Context Therapeutics 15.24 Mn -182.70 Mn - 201,360.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 201,360.00
Dec 31, 2025 110,410.00
Dec 31, 2024 218,816.00
Jun 30, 2023 7,522.00
Mar 31, 2023 29,892.00
Dec 31, 2022 51,967.00
Sep 30, 2022 73,752.00
Jun 30, 2022 95,251.00
Mar 31, 2022 116,467.00
API Access

Context Therapeutics Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=CNTX&period=max&api_key=YOUR_API_KEY